Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Distal Solutions was a private U.S. medical device engineering company focused on catheter-based research and development for interventional medical devices and implants. The company provided design, development, and consulting services to medtech customers rather than developing its own therapeutic drug pipeline. Founded by David Rezac in 2014, Distal Solutions built expertise in catheter delivery systems and related implant technologies for interventional applications. In May 2021, the company was acquired by Resonetics, which integrated the business to expand its interventional device design and development capabilities. Distal Solutions appears to remain active as an operating business or brand within the broader Resonetics organization rather than as an independent standalone company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Distal Solutions.